Harbin Gloria Pharmaceuticals Hits Day High with Strong 6.67% Intraday Surge

Harbin Gloria Pharmaceuticals Co., Ltd. has shown significant activity today, achieving a notable gain of 6.67% as of July 1, 2026. The stock reached an intraday high of CNY 2.96, reflecting a strong performance compared to the China Shanghai Composite, which only increased by 0.44% on the same day. Over the past week, Harbin Gloria has demonstrated an impressive 8.68% increase, further highlighting its recent upward momentum. However, the company's performance over the past month has been less favorable, with a decline of 3.68%. Year-to-date, the stock has faced challenges, showing a decrease of 6.19%, contrasting with the broader market's positive performance. Despite these fluctuations, Harbin Gloria maintains a mid-cap market capitalization of CNY 5,619 million. The company's return on equity stands at 15.80%, and it has a price-to-book ratio of 2.35. While the stock has faced difficulties in long-term growth, its recent activity indicates a moment of resilience in the current market environment.